G&H CEO Charlie Peppiatt featured in BioStock, commenting on Prolight Diagnostics collaboration
In April 2024, BioStock featured G&H CEO Charlie Peppiatt and Prolight Diagnostics' Head of Engineering, Paul Monaghan, discussing the progress of their collaboration on the development of Psyros, an innovative point-of-care (POC) system. Prolight Diagnostics has enlisted G&H | ITL for this project, aiming to revolutionize near-patient diagnostics by enabling quick, sensitive, and accurate testing of biomarkers, initially focusing on troponin for myocardial infarction detection.
Read more